Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Chonnam Medical Journal
|
January 17, 2012
The role of visfatin in diabetic nephropathy
Young Sun Kang, Dae Ryong Cha
Current Diabetes Reports
|
December 4, 2009
Aldosterone and diabetic kidney disease
Young Sun Kang, Dae Ryong Cha
Expert Opinion on Investigational Drugs
|
April 7, 2011
Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments
Young Sun Kang, Jin Joo Cha, Young Youl Hyun, et al.
Kidney Research and Clinical Practice
|
October 14, 2022
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, et al.
Life (Basel, Switzerland)
|
May 27, 2026
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice
Sang Youb Han, Jungyeon Ghee, Jin Joo Cha, et al.
Kidney Research and Clinical Practice
|
February 18, 2016
A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus
Kitae Kim, Jae Hyoung Lee, Sun Chul Kim, et al.
Kidney Research and Clinical Practice
|
March 12, 2021
Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy
Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, et al.
Diabetes Research and Clinical Practice
|
April 23, 2010
Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients
Young Sun Kang, Hye Kyoung Song, Mi Hwa Lee, et al.
Biochemical and Biophysical Research Communications
|
January 24, 2012
Recombinant fusion protein of albumin-retinol binding protein inactivates stellate cells
Soyoung Choi, Sangeun Park, Suhyun Kim, et al.
Inflammation
|
November 19, 2009
Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy
Kum Hyun Han, Sang Youb Han, Han Seong Kim, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Chonnam Medical Journal
|
January 17, 2012
The role of visfatin in diabetic nephropathy
Young Sun Kang, Dae Ryong Cha
Current Diabetes Reports
|
December 4, 2009
Aldosterone and diabetic kidney disease
Young Sun Kang, Dae Ryong Cha
Expert Opinion on Investigational Drugs
|
April 7, 2011
Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments
Young Sun Kang, Jin Joo Cha, Young Youl Hyun, et al.
Kidney Research and Clinical Practice
|
October 14, 2022
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, et al.
Life (Basel, Switzerland)
|
May 27, 2026
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice
Sang Youb Han, Jungyeon Ghee, Jin Joo Cha, et al.
Kidney Research and Clinical Practice
|
February 18, 2016
A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus
Kitae Kim, Jae Hyoung Lee, Sun Chul Kim, et al.
Kidney Research and Clinical Practice
|
March 12, 2021
Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy
Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, et al.
Diabetes Research and Clinical Practice
|
April 23, 2010
Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients
Young Sun Kang, Hye Kyoung Song, Mi Hwa Lee, et al.
Biochemical and Biophysical Research Communications
|
January 24, 2012
Recombinant fusion protein of albumin-retinol binding protein inactivates stellate cells
Soyoung Choi, Sangeun Park, Suhyun Kim, et al.
Inflammation
|
November 19, 2009
Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy
Kum Hyun Han, Sang Youb Han, Han Seong Kim, et al.
Page
of 9